Jove
Visualize
Contact Us

Related Experiment Video

Updated: Jun 25, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

[PSA kinetics after total prostatectomy].

J-M Riedinger1, N Eche, Y Fulla

  • 1Département de biologie et de pathologie des tumeurs, Centre Georges François Leclerc, Dijon. jriedinger@dijon.fnclcc.fr

Annales De Biologie Clinique
|February 5, 2009
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dihydropyrimidine dehydrogenase phenotype-guided dose individualization of fluoropyrimidine in gastrointestinal cancers: PRODIGE100-UCGI48-FUDOSE phase II study.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026
Same author

[Calcified bullet thrombus of the inferior vena cava and left renal vein in an adult].

Journal des maladies vasculaires·2016
Same author

Evidence of oxidative stress in very long chain fatty acid--treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins.

Neuroscience·2012
Same author

[Seventeenth-century brick ovens in Tourcoing, Nord].

Revue du Nord·2012
Same author

[Endocarditis due to Coxiella burnetti despite the absence of obvious exposure].

La Revue de medecine interne·2011
Same author

Selenoprotein P, rather than glutathione peroxidase, as a potential marker of septic shock and related syndromes.

European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes·2009
Same journal

[The role of the heart-on-a-chip to drug evaluation].

Annales de biologie clinique·2026
Same journal

A morphology-driven proof-of-concept study linking interphase nuclear abnormalities to dicentric-mediated genomic instability.

Annales de biologie clinique·2026
Same journal

Analytical validation and clinical concordance of Diazyme free light chain assays on the Cobas® platform compared with Freelite™.

Annales de biologie clinique·2026
Same journal

Small-cell secondary plasma cell leukemia mimicking low-grade B-cell lymphoma.

Annales de biologie clinique·2026
Same journal

[Multiple myeloma and analytical discrepancy in serum free light chain assay: a case report].

Annales de biologie clinique·2026
Same journal

[Summary of the 34th National Conference of the National College of Hospital Biochemistry].

Annales de biologie clinique·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Prostate specific antigen (PSA) monitoring after prostatectomy is crucial for detecting cancer recurrence. Dynamic PSA changes, not just thresholds, help determine recurrence and its location, guiding treatment decisions.

Area of Science:

  • Urology
  • Oncology
  • Biomarker Research

Context:

  • Prostate specific antigen (PSA) is a key biomarker for prostate cancer.
  • Interpreting PSA dynamics is more informative than fixed thresholds.
  • Post-prostatectomy PSA levels are critical for monitoring treatment efficacy.

Purpose:

  • To elucidate the significance of dynamic PSA changes in detecting prostate cancer recurrence after prostatectomy.
  • To establish criteria for defining and confirming PSA recurrence.
  • To assess the diagnostic value of PSA kinetics in predicting recurrence site.

Summary:

  • Post-prostatectomy, undetectable PSA (<0.1 microg/L) within a month indicates no residual cancer.
  • Recurrence is defined by PSA >0.2 microg/L confirmed by serial assays.

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer&#8212;Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Related Experiment Videos

Last Updated: Jun 25, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

A New Technique for Treating Low-risk Prostate Cancer&#8212;Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

  • PSA kinetics, initial stage, and Gleason score predict local vs. metastatic recurrence.

    • Impact:

    • Dynamic PSA monitoring improves early detection of prostate cancer recurrence.
    • Understanding PSA behavior aids in differentiating local vs. distant disease spread.
    • This approach enhances prognostic accuracy and informs personalized treatment strategies.